The Bluefield Project
Non-Profit & Charitable Organizations · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(415) 626-1501Website
www.bluefieldproject.orgRevenue
<$5 MillionIndustry
About The Bluefield Project
The Bluefield Project to Cure FTD is dedicated to advancing research and finding therapeutics for frontotemporal dementia (FTD) caused by mutations in the progranulin gene. They fund research, partner with industry, and have two drugs currently in clinical trials. The organization collaborates with a network of investigators and supports trainees in the field, aiming to develop effective treatments or cures for FTD. Their efforts are bolstered by a commitment to public engagement and fundraising to support ongoing research initiatives.Explore more
The Bluefield Project Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to The Bluefield Project
Compare insights from companies similar to The Bluefield Project, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
The Bluefield Project Tech Stack
A closer look at the technologies used by The Bluefield Project
See more technologies
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding The Bluefield Project
Sign Up For FreeTo access detailed company insights
The Bluefield Project to Cure FTD is dedicated to advancing research and finding therapeutics for frontotemporal dementia (FTD) caused by mutations in the progranulin gene. They fund research, partner with industry, and have two drugs currently in clinical trials. The organization collaborates with a network of investigators and supports trainees i... Read More
